Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2014

View Archived Issues

Alexar Therapeutics formed to develop LXR agonists

Gilead Sciences discloses new SYK inhibitors

Korean researchers present novel GPR119 receptor agonists for diabetes

The development of an orally available drug-loaded nanoparticle delivery system

First-in-class hKCC2 enhancers for the treatment of neurological diseases

RegeneRx receives orphan drug designation for thymosin beta4

RadioMedix receives orphan drug designation for GalioMedix

Neumedicines joins the Alliance for Biosecurity

Cornerstone Pharmaceuticals presents phase I results for CPI-613 in hematological malignancies

Nang Kuang Pharmaceutical begins phase II trial of ND-420, cisplatin and fluorouracil

Scioderm begins phase IIb study of SD-101 for rare genetic connective tissue disorder

FDA grants orphan drug status to DiaVacs' immunotherapy product for type 1 diabetes

TauRx adds new U.S. centers to clinical trials of investigational treatment for Alzheimer's disease

Mast Therapeutics reports promising data from study using chronic heart failure model

Taisho Pharmaceutical prepares new GlyT1 inhibitors for neurological and other disorders

Japanese group discloses new OX1/OX2 receptor antagonists

Oxygen Biotherapeutics posts protocol for phase III trial of levosimendan in North America

Kala Pharmaceuticals files IND for phase III program for ophthalmic nano-suspension product LE-MPP

Researchers from Curis present preliminary results of a first-in-human trial of CUDC-907

Epizyme reviews recent milestones, looks ahead to 2014

Neurocrine reports data from Kinect 2 study of NBI-98854 in tardive dyskinesia

FDA accepts for filing AEterna Zentaris' NDA for macimorelin acetate for AGHD

NPS Pharmaceuticals receives European orphan drug designation for Natpara

FDA grants fast track designation to Peregrine's immunotherapy bavituximab for second-line NSCLC

Oryzon begins clinical development of its novel LSD1 inhibitor for AML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...